Blood marker TREM-1 for heart problems in type 2 diabetes
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study looks at a blood marker called TREM-1 to see if it is higher in people with type 2 diabetes who also have heart problems. By measuring this marker, researchers hope to better understand and predict heart complications in diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with type 2 diabetes.
- You are willing to have a heart check-up (ECG, echocardiogram, or other tests).
- You do not have an active infection or acute inflammatory illness.
- You do not have advanced kidney disease, active cancer, liver disease, or an autoimmune disease being treated.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a wearable chest sensor (called HEMOTAG) to monitor heart events in people with long-standing Type 2 diabetes who also have heart disease or specific diabetes-related complications. The sensor is worn at home for short periods to catch early signs of heart trouble, aiming to improve personalized care.
This study follows adults with type 2 diabetes to see who may develop heart problems and who may have memory or thinking changes over time. It may help doctors better predict risk and plan earlier support.
This study looks at blood cells and blood type in people with type 2 diabetes to see if they can predict complications. It may help doctors better understand and manage diabetes-related health issues.
This study looks at blood tests (called biomarkers) to see if they can help predict chronic heart failure risk. It focuses on adults with type 2 diabetes over age 50 who do not already have certain heart conditions.
This study measures immune cells from your blood to find markers (biomarkers) that may explain or predict diabetic cardiomyopathy, a type of heart condition linked to diabetes. You may benefit mainly by being closely monitored and contributing to research that could improve future diagnosis or risk tracking.
This study looks at why people with type 2 diabetes develop heart problems. Researchers will examine special cells in your blood and inflammation markers to better understand these complications.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.